The Project Grant award for "DISSEMINATION OF A FACILITATION STRATEGY TO DEIMPLEMENT UNNECESSARY POST-OPERATIVE ANTIBIOTICS AT CHILDREN'S HOSPITALS" is funded by the Department of Health and Human Services Agency for Healthcare Research and Quality (AHRQ) under the Research on Healthcare Costs, Quality and Outcomes (CFDA 93.226) program. The $400,000 award aims to disseminate a virtual facilitation workshop to 20 U.S. children's hospitals to aid in de-implementing unnecessary...
This federal Project Grant award under the Research on Healthcare Costs, Quality and Outcomes (CFDA 93.226) program from the Agency for Healthcare Research and Quality (AHRQ) provides $148,882 to the University of Colorado-Denver to implement antibiotic stewardship strategies aimed at increasing oral antibiotic use among children hospitalized with pneumonia. The key objectives are to: 1) identify barriers and facilitators to increasing initial oral antibiotics for pediatric pneumonia patients;...
This Project Grant award of $873,716 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) aims to develop and evaluate the CARE, REVIEW, ASSESSMENT AND FEEDBACK TOOL (CRAFT) intervention to improve antibiotic prescribing practices for acute upper respiratory infections (URIs) in urgent outpatient care settings. The interdisciplinary research team at Vanderbilt University Medical Center (VUMC) will adapt the previously piloted...
This Project Grant award of $145,139 from the U.S. Department of Health and Human Services Agency for Healthcare Research and Quality (AHRQ) under the Research on Healthcare Costs, Quality and Outcomes (CFDA 93.226) program will support a research project conducted by the University of Kansas Medical Center Research Institute, Inc. (KUMCRI). The project aims to develop a patient-informed, equity-focused approach to measuring and addressing healthcare disparities in primary care settings. Key...
This Project Grant award from the Agency for Healthcare Research and Quality (AHRQ) under the Research on Healthcare Costs, Quality and Outcomes (CFDA 93.226) program supports research to identify sepsis phenotypes associated with antibiotic-resistant pathogens. The award of $294,244 to The General Hospital Corporation (doing business as Massachusetts General Hospital) aims to: 1) Apply large language models to clinical notes to extract data on presenting syndromes, antibiotic exposures, and...
The University of Texas Health Science Center at Houston received a Project Grant award of $275,000 from the Agency for Healthcare Research and Quality (AHRQ) under the federal Research on Healthcare Costs, Quality and Outcomes (CFDA 93.226) program. The grant aims to develop and test strategies to increase implementation of evidence-based interventions in collaboration with patient advocacy groups in the areas of juvenile idiopathic arthritis, multiple sclerosis, and necrotizing enterocolitis...
This Project Grant award for $490,093 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports the development of a novel microfluidic-enabled platform for rapid antibiotic susceptibility testing. The University of Maryland, College Park will use this funding to create a system that can isolate bacteria directly from whole blood, identify bacterial pathogens, and evaluate their antibiotic response...
This Project Grant award from the Agency for Healthcare Research and Quality (AHRQ) under the Research on Healthcare Costs, Quality and Outcomes (CFDA 93.226) program provides $490,523 to Vanderbilt University Medical Center to adapt and implement a risk-stratified penicillin allergy evaluation approach in key outpatient settings. The project aims to: 1) measure efficacy, barriers and facilitators of outpatient antibiotic allergy assessment for surgical, transplant and obstetric patients, 2)...
This is a $398,972 Project Grant awarded by the Agency for Healthcare Research and Quality (AHRQ) under the Research on Healthcare Costs, Quality and Outcomes (CFDA 93.226) federal grant program. The grant is focused on studying hospital care practices and outcomes for newborns with prenatal substance exposure, with the goal of identifying high-quality and equitable care approaches that can be implemented across U.S. birth hospitals. The project will be conducted in partnership with the Better...
This federal Project Grant award from the Department of Health and Human Services Agency for Healthcare Research and Quality (AHRQ) under the Research on Healthcare Costs, Quality and Outcomes (CFDA 93.226) program will fund a $799,998 research project at Georgetown University to evaluate the use and expenditures on low-quality breast cancer care in the Medicare program. The key objectives are to: 1) Assess differences in receipt of low-value breast cancer care across traditional Medicare (TM)...